Nalidixic acid: an antibacterial paradox.

Area of Science:

• Microbiology
• Pharmacology

Background:

• Nalidixic acid exhibits varying bactericidal and bacteriostatic effects against gram-negative bacteria at different concentrations.
• Understanding the concentration-dependent mechanism of action is crucial for optimizing its therapeutic use.

Purpose of the Study:

• To investigate the mode of action of nalidixic acid at bactericidal and bacteriostatic concentrations.
• To elucidate the molecular targets affected by nalidixic acid in bacteria.

Main Methods:

• Bacterial cultures of various gram-negative species were exposed to different concentrations of nalidixic acid.
• Inhibition of deoxyribonucleic acid, ribonucleic acid (RNA), and protein synthesis was measured at various drug concentrations.

Main Results:

• Nalidixic acid demonstrated maximum bactericidal activity against gram-negative bacteria at 50-200 µg/ml.
• At these concentrations, only deoxyribonucleic acid synthesis was inhibited.
• At higher concentrations (around 400 µg/ml), nalidixic acid became bacteriostatic, inhibiting both RNA and protein synthesis.
• Protein synthesis inhibition appears secondary to RNA synthesis inhibition, suggesting RNA synthesis as a second target at higher concentrations.

Conclusions:

• The bactericidal and bacteriostatic effects of nalidixic acid are concentration-dependent.
• At optimal bactericidal concentrations, nalidixic acid primarily targets deoxyribonucleic acid synthesis.
• At higher, less bactericidal concentrations, nalidixic acid inhibits RNA and protein synthesis, with RNA synthesis being a likely secondary target.